Income Statement

Currency: CAD

	Oct-2021	Jan-2022	Apr-2022	Jul-2022	Oct-2022	Jan-2023	Apr-2023	Jul-2023	Oct-2023	Jan-2024	Apr-2024	Jul-2024
Revenue
Interest Expense	1	2	3	4	6	8	10	12	13	14	14	15
Revenue	14 N/A	16 +18%	18 +13%	18 +2%	28 +50%	37 +32%	45 +24%	53 +18%	54 +1%	54 +1%	55 +1%	53 -3%
Gross Profit
Cost of Revenue	(10)	(11)	(12)	(12)	(21)	(28)	(34)	(40)	(41)	(43)	(45)	(45)
Gross Profit	4 N/A	5 +26%	6 +19%	6 +1%	6 +5%	9 +37%	11 +32%	13 +18%	13 -3%	12 -11%	10 -13%	9 -12%
Operating Income
Operating Expenses	(17)	(21)	(24)	(25)	(25)	(27)	(29)	(31)	(30)	(30)	(29)	(28)
Selling, General & Administrative	(16)	(20)	(24)	(25)	(25)	(26)	(28)	(30)	(30)	(29)	(29)	(27)
Depreciation & Amortization	(0)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)	(1)
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0
Operating Income	(13) N/A	(16) -29%	(18) -14%	(19) -5%	(19) +1%	(19) +3%	(17) +6%	(17) +1%	(17) +1%	(18) -6%	(19) -6%	(19) +1%
Pre-Tax Income
Interest Income Expense	(1)	(2)	(3)	(4)	(7)	(8)	(11)	(11)	(13)	(14)	(15)	(17)
Non-Reccuring Items	(0)	0	0	0	(0)	0	0	0	0	0	0	(1)
Total Other Income	(0)	(0)	(0)	(0)	(0)	(0)	(1)	(1)	3	3	4	4
Pre-Tax Income	(14) N/A	(18) -30%	(22) -18%	(23) -8%	(27) -15%	(27) -1%	(29) -5%	(30) -4%	(28) +7%	(28) -2%	(30) -5%	(32) -8%
Net Income
Tax Provision	0	0	0	0	1	0	0	0	0	0	0	0
Income from Continuing Operations	(14)	(18)	(22)	(23)	(26)	(26)	(28)	(29)	(28)	(28)	(30)	(32)
Net Income (Common)	(14) N/A	(18) -30%	(22) -18%	(23) -8%	(26) -10%	(26) -1%	(28) -5%	(29) -4%	(28) +3%	(28) -2%	(30) -5%	(32) -8%
EPS (Diluted)	-0.2 N/A	-0.24 -20%	-0.28 -17%	-0.29 -4%	-0.32 -10%	-0.32 N/A	-0.33 -3%	-0.35 -6%	-0.32 +9%	-0.33 -3%	-0.3 +9%	-0.34 -13%

Valeo Pharma Inc
TSX:VPH